After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...

To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...

GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.